ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma
本文未提供摘要,请点击“查看全文”查看完整内容。